Pioglitazone in early Parkinson's disease: A phase 2, multicentre, double-blind, randomised trial

Tanya Simuni, Karl Kieburtz, Barbara Tilley, Jordan J Elm, Bernard Ravina, Debra Babcock, Marina Emborg, Robert Hauser, Cornelia Kamp, John C. Morgan, G. Webster Ross, David K Simon, Jacci Bainbridge, Liana Baker, Ivan Bodis-Wollner, James Boyd, Franca Cambi, Julie Carter, Kelvin Chou, Nabila DahodwalaRichard B. Dewey, Rohit Dhall, John Fang, Buff Farrow, Andrew Feigin, Sofya Glazman, John Goudreau, Pauline LeBlanc, Stephen Lee, Maureen Leehey, Mark F. Lew, Stephanie Lowenhaupt, Sheng Luo, Rajesh Pahwa, Adriana Perez, Jay Schneider, Burton Scott, Binit Shah, Kathleen M. Shannon, Saloni Sharma, Carlos Singer, Daniel Truong, Renee Wagner, Karen Williams, Anne Marie Wills, Pei Shieen Wong, Cindy Zadikoff, Richard Zweig

Neurology & Neurotherapeutics - NE Movement Disorders Section
Neurology & Neurotherapeutics

Research output: Contribution to journal › Article › peer-review

200 Scopus citations

Sort by
Weight
Alphabetically

Pioglitazone in early Parkinson's disease: A phase 2, multicentre, double-blind, randomised trial

Fingerprint

Medicine & Life Sciences